STOCK TITAN

Crexendo Inc Financials

CXDO
FY2025 annual
Revenue $68.2M +12.0% YoY
Net Income $5.1M +202.4% YoY
EPS (Diluted) $0.16 +166.7% YoY
Free Cash Flow $9.3M +48.3% YoY
Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Currency USD FYE December

Crexendo Inc (CXDO) reported $68.2M in revenue for fiscal year 2025, up 12.0% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI CXDO FY2025

Crexendo’s dominant mechanic is a low-reinvestment model converting improving operating margins into cash while carrying minimal debt.

The shift from a -99.6% operating margin in FY2022 to 6.9% in FY2025 coincided with revenue reaching $68.2M, while selling, general and administrative expense rose only modestly from $12.9M to $14.7M. That pairing points to operating-cost absorption rather than margin expansion being explained solely by top-line growth.

Cash generation is running ahead of reported earnings: FY2025 operating cash flow was $9.3M versus net income of $5.1M, and free cash flow was nearly identical to operating cash flow. This indicates that accounting profit is converting into cash without substantial reinvestment demands.

The balance sheet has become materially more liquid and less debt-dependent: the current ratio reached 3.4x in FY2025 while debt-to-equity fell to 0.0x from 0.3x in FY2023. Current assets of $41.9M were more than three times current liabilities of $12.3M, giving working capital a larger role in financing operations.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Cash Runway Dilution R&DIntensity Revenue Progress BurnTrend BalanceSheet 52 / 100
Financial Health Score 52/100
Scored as: Emerging companies peer group

Scored against emerging companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of Crexendo Inc's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Cash Runway
85
Dilution
47
R&D Intensity
34
Revenue Progress
65
Burn Trend
0

Not available for Crexendo Inc, and counted as zero in the overall score.

Balance Sheet
78
Altman Z-Score Safe
8.57

Crexendo Inc scores 8.57, well above the 2.99 safe threshold. The score is driven primarily by a large market capitalization ($196.5M) relative to total liabilities ($13.9M). This indicates low bankruptcy risk based on profitability, leverage, and asset efficiency.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Partial
6/8

Crexendo Inc passes 6 of 8 computable financial strength tests (1 of the nine could not be computed from available data). All 4 profitability signals pass (positive income, cash flow, and earnings quality), 2 of 3 leverage/liquidity signals pass, neither operating efficiency signal passes.

Earnings Quality Cash-Backed
1.83x

For every $1 of reported earnings, Crexendo Inc generates $1.83 in operating cash flow ($9.3M OCF vs $5.1M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Interest Coverage Safe
246.84x

Crexendo Inc earns $246.84 in operating income for every $1 of interest expense ($4.7M vs $19K). This wide margin provides strong safety for debt servicing, even if earnings decline temporarily.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
$68.2M
YoY+12.0%
5Y CAGR+33.0%
10Y CAGR+24.2%

Crexendo Inc generated $68.2M in revenue in fiscal year 2025. This represents an increase of 12.0% from the prior year.

EBITDA
$4.9M
YoY+130.7%
5Y CAGR+31.5%

Crexendo Inc's EBITDA was $4.9M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 130.7% from the prior year.

Net Income
$5.1M
YoY+202.4%
5Y CAGR-8.6%

Crexendo Inc reported $5.1M in net income in fiscal year 2025. This represents an increase of 202.4% from the prior year.

EPS (Diluted)
$0.16
YoY+166.7%

Crexendo Inc earned $0.16 per diluted share (EPS) in fiscal year 2025. This represents an increase of 166.7% from the prior year.

Cash & Balance Sheet

Free Cash Flow
$9.3M
YoY+48.3%

Crexendo Inc generated $9.3M in free cash flow in fiscal year 2025, representing cash available after capex. This represents an increase of 48.3% from the prior year.

Cash & Debt
$31.4M
YoY+72.5%
5Y CAGR+12.2%
10Y CAGR+35.6%

Crexendo Inc held $31.4M in cash against $114K in long-term debt as of fiscal year 2025.

Shares Outstanding
31M
YoY+11.7%

Crexendo Inc had 31M shares outstanding in fiscal year 2025. This represents an increase of 11.7% from the prior year.

Dividends Per Share

Not reported for fiscal year 2025.

Margins & Returns

Operating Margin
6.9%
YoY+3.9pp
5Y CAGR+0.8pp
10Y CAGR+68.7pp

Crexendo Inc's operating margin was 6.9% in fiscal year 2025, reflecting core business profitability. This is up 3.9 percentage points from the prior year.

Net Margin
7.4%
YoY+4.7pp
5Y CAGR-41.0pp
10Y CAGR+65.5pp

Crexendo Inc's net profit margin was 7.4% in fiscal year 2025, showing the share of revenue converted to profit. This is up 4.7 percentage points from the prior year.

Return on Equity
8.0%
YoY+4.7pp
5Y CAGR-22.9pp
10Y CAGR+214.0pp

Crexendo Inc's ROE was 8.0% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is up 4.7 percentage points from the prior year.

Gross Margin

Not reported for fiscal year 2025.

Capital Allocation

R&D Spending
$5.7M
YoY+3.0%
5Y CAGR+36.9%
10Y CAGR+22.1%

Crexendo Inc invested $5.7M in research and development in fiscal year 2025. This represents an increase of 3.0% from the prior year.

Capital Expenditures
$18K
YoY-33.3%

Crexendo Inc invested $18K in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents a decrease of 33.3% from the prior year.

Share Buybacks

Not reported for fiscal year 2025.

CXDO Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

CXDO quarterly income statement
MetricQ2'26Q1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24
Revenue$24.6M+19.0%$20.7M+14.7%$18.1M+3.2%$17.5M+5.7%$16.6M+3.1%$16.1M-1.1%$16.2M+3.9%$15.6M
R&D Expenses$1.8M+16.8%$1.6M+16.4%$1.3M-4.8%$1.4M-1.6%$1.4M-5.6%$1.5M+1.4%$1.5M+2.0%$1.5M
SG&A Expenses$5.3M+5.5%$5.1M+31.7%$3.8M+1.6%$3.8M+5.4%$3.6M+1.9%$3.5M+3.3%$3.4M-7.8%$3.7M
Operating Income$1.1M+139.8%$440K-61.1%$1.1M-13.3%$1.3M+18.3%$1.1M-4.1%$1.1M+83.7%$626K+363.7%$135K
Interest Expense-$62K$0N/A$0$0$0N/A$7K
Income Tax$25K-13.8%$29KN/A$43K-10.4%$48K+9.1%$44KN/A$46K
Net Income$1.1M+81.8%$578K-52.5%$1.2M-16.0%$1.4M+17.7%$1.2M+5.2%$1.2M+131.0%$507K+242.6%$148K
EPS (Diluted)$0.03+50.0%$0.02-50.0%$0.04-20.0%$0.05+25.0%$0.040.0%$0.04+100.0%$0.02$0.00

Not reported in any period shown, so not listed: Cost of Revenue, Gross Profit.

CXDO Balance Sheet

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

CXDO quarterly balance sheet
MetricQ2'26Q1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24
Total Assets$101.0M+10.7%$91.3M+17.5%$77.7M+2.3%$76.0M+6.4%$71.4M+5.8%$67.4M+3.9%$64.9M+4.3%$62.3M
Current Assets$34.8M+51.1%$23.0M-45.0%$41.9M+6.6%$39.3M+13.5%$34.6M+14.9%$30.1M+12.2%$26.9M+12.6%$23.9M
Cash & Equivalents$18.3M+152.3%$7.2M-76.9%$31.4M+9.8%$28.6M+21.8%$23.4M+10.6%$21.2M+16.6%$18.2M+17.7%$15.5M
Inventory$1.4M+17.9%$1.2M+157.7%$454K-29.1%$640K+3.6%$618K+7.3%$576K+46.6%$393K-24.1%$518K
Accounts Receivable$6.2M-2.9%$6.4M+29.7%$4.9M+3.5%$4.7M-15.5%$5.6M+38.4%$4.1M-6.7%$4.4M+16.0%$3.8M
Goodwill$14.2M+708400.0%$2K-100.0%$9.5M0.0%$9.5M0.0%$9.5M0.0%$9.5M0.0%$9.5M0.0%$9.5M
Total Liabilities$22.9M+23.5%$18.6M+33.9%$13.9M-5.1%$14.6M+11.9%$13.1M+6.8%$12.2M-9.6%$13.5M+5.8%$12.8M
Current Liabilities$16.9M+0.8%$16.8M+36.2%$12.3M-9.3%$13.6M+12.4%$12.1M+8.8%$11.1M-8.1%$12.1M+8.5%$11.2M
Long-Term DebtN/AN/A$114K-51.7%$236K-33.7%$356K-25.1%$475K-19.8%$592K-16.5%$709K
Total Equity$78.1M+7.4%$72.7M+13.9%$63.8M+4.0%$61.3M+5.2%$58.3M+5.6%$55.2M+7.4%$51.4M+3.9%$49.5M
Retained Earnings-$80.1M+1.3%-$81.1M+0.7%-$81.7M+1.5%-$82.9M+1.7%-$84.4M+1.4%-$85.6M+1.3%-$86.8M+0.6%-$87.3M

CXDO Cash Flow Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

CXDO quarterly cash flow statement
MetricQ2'26Q1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24
Operating Cash Flow$2.8M+35.1%$2.0M-13.2%$2.3M-46.9%$4.4M+241.1%$1.3M+4.6%$1.2M-43.1%$2.2M+34.3%$1.6M
Capital ExpendituresN/AN/A$0$0-100.0%$18K$0-100.0%$27K$0
Free Cash FlowN/AN/A$2.3M-46.9%$4.4M+245.9%$1.3M+3.2%$1.2M-42.4%$2.1M+32.6%$1.6M
Investing Cash Flow$1K+100.0%-$26.2M$0$0+100.0%-$18K$0+100.0%-$27K$0
Financing Cash Flow$8.3M+13482.0%$61K-86.8%$461K-36.4%$725K-22.3%$933K-47.1%$1.8M+201.9%$584K+150.6%$233K
Dividends PaidN/AN/AN/AN/AN/AN/A$0$0

Not reported in any period shown, so not listed: Share Buybacks.

CXDO Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples.

CXDO quarterly financial ratios
MetricQ2'26Q1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24
Operating Margin4.3%+2.2pp2.1%-4.2pp6.3%-1.2pp7.5%+0.8pp6.7%-0.5pp7.2%+3.3pp3.9%+3.0pp0.9%
Net Margin4.3%+1.5pp2.8%-4.0pp6.7%-1.6pp8.3%+0.9pp7.4%+0.1pp7.3%+4.2pp3.1%+2.2pp0.9%
Return on Equity1.4%+0.6pp0.8%-1.1pp1.9%-0.5pp2.4%+0.2pp2.1%0.0pp2.1%+1.1pp1.0%+0.7pp0.3%
Return on Assets1.0%+0.4pp0.6%-0.9pp1.6%-0.3pp1.9%+0.2pp1.7%0.0pp1.7%+1.0pp0.8%+0.5pp0.2%
Current Ratio2.06+0.7x1.37-2.0x3.40+0.5x2.890.0x2.86+0.1x2.71+0.5x2.22+0.1x2.14
Debt-to-Equity0.290.0x0.26+0.3x0.000.0x0.000.0x0.010.0x0.010.0x0.010.0x0.01
FCF MarginN/AN/A13.0%-12.3pp25.2%+17.5pp7.7%0.0pp7.7%-5.5pp13.2%+2.9pp10.4%

Not reported in any period shown, so not listed: Gross Margin.

Similar Companies

Frequently Asked Questions

What is Crexendo Inc's annual revenue?

Crexendo Inc (CXDO) reported $68.2M in total revenue for fiscal year 2025. This represents a 12.0% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Crexendo Inc's revenue growing?

Crexendo Inc (CXDO) revenue grew by 12.0% year-over-year, from $60.8M to $68.2M in fiscal year 2025.

Is Crexendo Inc profitable?

Yes, Crexendo Inc (CXDO) reported a net income of $5.1M in fiscal year 2025, with a net profit margin of 7.4%.

Crexendo Inc (CXDO) reported diluted earnings per share of $0.16 for fiscal year 2025. This represents a 166.7% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Crexendo Inc (CXDO) had EBITDA of $4.9M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

As of fiscal year 2025, Crexendo Inc (CXDO) had $31.4M in cash and equivalents against $114K in long-term debt.

Crexendo Inc (CXDO) had an operating margin of 6.9% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

Crexendo Inc (CXDO) had a net profit margin of 7.4% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

Crexendo Inc (CXDO) has a return on equity of 8.0% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

Crexendo Inc (CXDO) generated $9.3M in free cash flow during fiscal year 2025. This represents a 48.3% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

Crexendo Inc (CXDO) generated $9.3M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

Crexendo Inc (CXDO) had $77.7M in total assets as of fiscal year 2025, including both current and long-term assets.

Crexendo Inc (CXDO) invested $18K in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

Crexendo Inc (CXDO) invested $5.7M in research and development during fiscal year 2025.

Crexendo Inc (CXDO) had 31M shares outstanding as of fiscal year 2025.

Crexendo Inc (CXDO) had a current ratio of 3.40 as of fiscal year 2025, which is generally considered healthy.

Crexendo Inc (CXDO) had a debt-to-equity ratio of 0.00 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

Crexendo Inc (CXDO) had a return on assets of 6.5% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

Crexendo Inc (CXDO) has an Altman Z-Score of 8.57, placing it in the Safe Zone (low bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

Crexendo Inc (CXDO) has a Piotroski F-Score of 6 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Crexendo Inc (CXDO) has an earnings quality ratio of 1.83x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Crexendo Inc (CXDO) has an interest coverage ratio of 246.84x, meaning it can comfortably cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

Crexendo Inc (CXDO) scores 52 out of 100 on our Financial Health Score, indicating moderate standing within its emerging companies peer group. The score is a 0-100 composite of six dimensions (Cash Runway, Dilution, R&D Intensity, Revenue Progress, Burn Trend, Balance Sheet), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.

Back to top